Effectiveness of OK-432 (Sapylin) to Reduce Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

详细信息    查看全文

• 作者：Yinlong Yang MD (1)
  Erli Gao MD (1)
  Xinying Liu MD (2)
  Zhiqiang Ye MD (1)
  Yizuo Chen MD (1)
  Quan Li MD (1)
  Jinmiao Qu MD (1)
  Xuanxuan Dai MD (1)
  Ouchen Wang MD (1)
  Yifei Pan MD (1)
  Xiaohua Zhang MD (1)
  
• 刊名：Annals of Surgical Oncology
• 出版年：2013
• 出版时间：May 2013
• 年：2013
• 卷：20
• 期：5
• 页码：1500-1504
• 全文大小：189KB
• 参考文献：1. Abe M, Iwase T, Takeuchi T, Murai H, Miura S. A randomized controlled trial on the prevention of seroma after partial or total mastectomy and axillary lymph node dissection. / Breast Cancer. 1998;5:67-. CrossRef
  2. Classe JM, Dupre PF, Francois T, Robard S, Theard JL, Dravet F. Axillary padding as an alternative to closed suction drain for ambulatory axillary lymphadenectomy: a prospective cohort of 207 patients with early breast cancer. / Arch Surg. 2002;137:169-2. CrossRef
  3. Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. / Ann Surg. 1999;230:194-01. CrossRef
  4. Somers RG, Jablon LK, Kaplan MJ, Sandler GL, Rosenblatt NK. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer. A prospective randomized trial. / Ann Surg. 1992;215:146-. CrossRef
  5. Woodworth PA, McBoyle MF, Helmer SD, Beamer RL. Seroma formation after breast cancer surgery: incidence and predicting factors. / Am Surg. 2000;66:444-0.
  6. Burak WE Jr, Goodman PS, Young DC, Farrar WB. Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. / J Surg Oncol. 1997;64:27-1. CrossRef
  7. Gonzalez EA, Saltzstein EC, Riedner CS, Nelson BK. Seroma formation following breast cancer surgery. / Breast J. 2003;9:385-. CrossRef
  8. Moore MM, Freeman MG. Fibrin sealant in breast surgery. / J Long Term Eff Med Implants. 1998;8:133-2.
  9. Pogson CJ, Adwani A, Ebbs SR. Seroma following breast cancer surgery. / Eur J Surg Oncol. 2003;29:711-. CrossRef
  10. Chaturvedi P, Chaturvedi U. Axillary compression with delayed drain removal reduces prolonged seroma formation. / J Surg Oncol. 2001;78:279-0. CrossRef
  11. O’Hea BJ, Ho MN, Petrek JA. External compression dressing versus standard dressing after axillary lymphadenectomy. / Am J Surg. 1999;177:450-. CrossRef
  12. Shamley DR, Barker K, Simonite V, Beardshaw A. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. / Breast Cancer Res Treat. 2005;90:263-1. CrossRef
  13. Galatius H, Okholm M, Hoffmann J. Mastectomy using ultrasonic dissection: effect on seroma formation. / Breast. 2003;12:338-1. CrossRef
  14. Lumachi F, Brandes AA, Burelli P, Basso SM, Iacobone M, Ermani M. Seroma prevention following axillary dissection in patients with breast cancer by using ultrasound scissors: a prospective clinical study. / Eur J Surg Oncol. 2004;30:526-0. CrossRef
  15. Divino CM, Kuerer HM, Tartter PI. Drains prevent seromas following lumpectomy with axillary dissection. / Breast J. 2000;6:31-. CrossRef
  16. Kopelman D, Klemm O, Bahous H, Klein R, Krausz M, Hashmonai M. Postoperative suction drainage of the axilla: for how long? Prospective randomised trial. / Eur J Surg. 1999;165:117-0. CrossRef
  17. Talbot ML, Magarey CJ. Reduced use of drains following axillary lymphadenectomy for breast cancer. / ANZ J Surg. 2002;72:488-0. CrossRef
  18. Berger A, Tempfer C, Hartmann B, Kornprat P, Rossmann A, Neuwirth G, et al. Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study. / Breast Cancer Res Treat. 2001;67:9-4. CrossRef
  19. Dinsmore RC, Harris JA, Gustafson RJ. Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. / Am Surg. 2000;66:982-.
  20. Moore M, Burak WE Jr, Nelson E, Kearney T, Simmons R, Mayers L, et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. / J Am Coll Surg. 2001;192:591-. CrossRef
  21. Rice DC, Morris SM, Sarr MG, Farnell MB, van Heerden JA, Grant CS, et al. Intraoperative topical tetracycline sclerotherapy following mastectomy: a prospective, randomized trial. / J Surg Oncol. 2000;73:224-. CrossRef
  22. Coons MS, Folliguet TA, Rodriguez C, Woloszyn TT, Tuchler RE, Marini CP. Prevention of seroma formation after dissection of musculocutaneous flaps. / Am Surg. 1993;59:215-.
  23. Okamoto H, Shoin S, Koshimura S, Shimizu R. Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. / Jpn J Microbiol. 1967;11:323-.
  24. Kikkawa F, Kawai M, Oguchi H, Kojima M, Ishikawa H, Iwata M, et al. Randomised study of immunotherapy with OK-432 in uterine cervical carcinoma. / Eur J Cancer. 1993;29A:1542-. CrossRef
  25. Maehara Y, Okuyama T, Kakeji Y, Baba H, Furusawa M, Sugimachi K. Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. / Am J Surg. 1994;168:36-0. CrossRef
  26. Matsubara N, Itoh K, Mukai H, Nagai S. Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases. / Int J Clin Oncol. 2012;17:470-. CrossRef
  27. Tano T, Okamoto M, Kan S, Nakashiro K, Shimodaira S, Yamashita N, et al. Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines. / Oral Oncol. 2012;48:678-5. CrossRef
  28. Kitsuki H, Katano M, Ikubo A, Morisaki T, Anann K, Tanaka M et al. Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-gamma in enhancement of surface expression of ICAM-1 on tumor cells in vivo. / Clin Immunol Immunopathol. 1996;78:283-0. CrossRef
  29. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. / J Clin Oncol. 2007;25:3657-3. CrossRef
  30. Watt-Boolsen S, Nielsen VB, Jensen J, Bak S. Postmastectomy seroma. A study of the nature and origin of seroma after mastectomy. / Dan Med Bull. 1989;36:487-.
  31. Bonnema J, Ligtenstein DA, Wiggers T, van Geel AN. The composition of serous fluid after axillary dissection. / Eur J Surg. 1999;165:9-3. CrossRef
  32. Cipolla C, Fricano S, Vieni S, Graceffa G, Licari G, Torcivia A, et al. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients. / J Surg Oncol. 2010;101:600-. CrossRef
  33. Jain PK, Sowdi R, Anderson AD, MacFie J. Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. / Br J Surg. 2004;91:54-0. CrossRef
  34. Ruggiero R, Procaccini E, Piazza P, Docimo G, Iovino F, Antoniol G, et al. Effectiveness of fibrin glue in conjunction with collagen patches to reduce seroma formation after axillary lymphadenectomy for breast cancer. / Am J Surg. 2008;196:170-. CrossRef
  35. Soon PS, Clark J, Magarey CJ. Seroma formation after axillary lymphadenectomy with and without the use of drains. / Breast. 2005;14:103-. CrossRef
  36. Porter KA, O’Connor S, Rimm E, Lopez M. Electrocautery as a factor in seroma formation following mastectomy. / Am J Surg. 1998;176:8-1. CrossRef
  37. Katano M, Morisaki T. The past, the present and future of the OK-432 therapy for patients with malignant effusions. / Anticancer Res. 1998;18:3917-5.
  38. Poldervaart MT, Breugem CC, Speleman L, Pasmans S. Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature. / J Craniofac Surg. 2009;20:1159-2. CrossRef
  39. Smith MC, Zimmerman MB, Burke DK, et al. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. / Laryngoscope. 2009;119:107-5. CrossRef
  
• 作者单位：Yinlong Yang MD (1)
  Erli Gao MD (1)
  Xinying Liu MD (2)
  Zhiqiang Ye MD (1)
  Yizuo Chen MD (1)
  Quan Li MD (1)
  Jinmiao Qu MD (1)
  Xuanxuan Dai MD (1)
  Ouchen Wang MD (1)
  Yifei Pan MD (1)
  Xiaohua Zhang MD (1)
  
  1. Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, Zhejiang, People’s Republic of China
  2. Department of Ultrasound, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, Zhejiang, People’s Republic of China
  

文摘

Background The occurrence of seroma formation after axillary lymphadenectomy for breast cancer cannot be ignored. Various approaches have been used in an effort to reduce it, but these results are still controversial. We aimed to describe a new method of application of OK-432 (Sapylin, heat-treated Su strain of Streptococcus) to reduce seroma formation after axillary lymphadenectomy for breast cancer and to verify the safety and efficacy of it as a beneficial supplement for conventional surgery. Methods A prospective, randomized analysis of consecutive quadrantectomy or mastectomy plus axillary lymphadenectomy using or not using OK-432 was designed. From July 2010 to November 2011, a total of 111 patients were enrolled in this prospective, randomized study and completed the follow-up. OK-432 applied to the axillary fossa plus placement of closed suction drainage was used in 54 patients (the experimental group); placement of closed suction drainage was used in 57 patients (the control group). Results There were no statistical significance between the two groups in terms of age, body mass index, treatment received, tumor size, number of removed lymph nodes, and lymph node status. Postoperative drainage magnitude and duration were significantly reduced in the experimental group (P?=?0.008 and 0.003, respectively). One week after hospital discharge, fewer patients developed a palpable seroma in the experimental group: 10 in the experimental group versus 28 in the control group (P?=?0.001). Fewer seromas needed aspiration (mean 1 [range 0-] in the experimental group vs. mean 4 [range 1-] in the control group; P?<?0.001). There were no significant differences in terms of the incidence of complications associated with axillary lymphadenectomy (P?=?0.941). Conclusions OK-432 is a feasible and safe option for axillary lymphadenectomy for breast cancer. The use of it does not always prevent seroma formation, but it can reduce drainage magnitude and duration, as well as decrease the incidence of seroma after the removal of drainage. It may be increasingly conducted in day surgery clinics.